A Phase II Study of Telaprevir (Vx-950) in Combination With Peginterferon Alfa 2a (Pegasys) and Ribavirin (Copegus)..... Grant uri icon

date/time interval

  • January 24, 2007 - November 21, 2009

total award amount

  • 137605.00

direct costs

  • 110084.00

sponsor award ID

  • VX-950-106

local award ID

  • 00063474